The use of established methods and innovative tailored solutions in our HEOR, for the pharmaceutical, biotech and medical device clients, generate HEOR evidence, meet specific HTA challenges, support market access, and reinforce arguments for product reimbursement. Development of global HEOR strategy, including strategic roadmaps and evidence generation for product planning, and advisory boards to validate the strategy and regulatory support for FDA and EMA can be accelerated.
Our Expertise